Upload
felichi-dacumos-balajadia
View
219
Download
0
Embed Size (px)
Citation preview
8/18/2019 Unit 1-Review of ANS
1/27
PHARMACOLOGY 2 and
THERAPEUTICS
8/18/2019 Unit 1-Review of ANS
2/27
Topic One:Autonomic Nervous System
Learning Objective: Recall and review the principles of ANS
1. To review the organization, functional components, andphysiologic roles of the autonomic nervous system
2. To describe the synthesis, storage, release, reuptake,and metabolism of the major neurotransmitters in theautonomic nervous system
8/18/2019 Unit 1-Review of ANS
3/27
8/18/2019 Unit 1-Review of ANS
4/27
8/18/2019 Unit 1-Review of ANS
5/27
ENTERICPARASYMPATHETIC
SYMPATHETIC
8/18/2019 Unit 1-Review of ANS
6/27
AUTONOMIC NERVOUS SYSTEMCriteria Sympathetic
(Adrenergic)
Parasympathetic
(Cholinergic)
Anatomy Thoracolumbar Craniosacral
Length of Neurons Pre-ganglion: SHORTPost-ganglion: LONG
Pre-ganglion: LONGPost-ganglion: SHORT
Location of theGanglion
Near the spinal cord Near the target organ
Neurotransmitter Pre-ganglion: ACh
Post-ganglion: NE,Dopamine, Epinephrine(Hormone)
Pre-ganglion: ACh
Post-ganglion: ACh
Receptors Ganglion: NNTarget Organ: alpha,
beta, dopa
Ganglion: NNTarget Organ:
Muscarinic, Nicotinic
8/18/2019 Unit 1-Review of ANS
7/27
ANS NEUROTRANSMITTERS
• Adrenergic(Sympathetic)
• Cholinergic(Parasympathetic)
8/18/2019 Unit 1-Review of ANS
8/27
8/18/2019 Unit 1-Review of ANS
9/27
Sympathetic innervation of the adrenal medulla
acetylcholine
Adrenergic receptor
Nicotinic receptor
Adrenal medulla
Epinephrine is released into the blood
Ganglionic
neuron
Ganglionic transmitter
Neuroeffectortransmitter
8/18/2019 Unit 1-Review of ANS
10/27
AUTONOMIC NERVOUS SYSTEM
8/18/2019 Unit 1-Review of ANS
11/27
CHOLINERGIC TRANSMISSION
ADRENERGIC TRANSMISSION
8/18/2019 Unit 1-Review of ANS
12/27
8/18/2019 Unit 1-Review of ANS
13/27
SYNTHESIS
STORAGE
RELEASE
TERMINATION
8/18/2019 Unit 1-Review of ANS
14/27
8/18/2019 Unit 1-Review of ANS
15/27
uptake
uptake
SYNTHESIS
STORAGE
RELEASE
TERMINATION
8/18/2019 Unit 1-Review of ANS
16/27
Biosynthesis & Metabolism of
Catecholamines
Tyrosine
DOPA
Dopamine
NE
Tyrosine hydroxylase
ALAAD
Dopamine β-hydroxylase
NE, Epi
MAO
Dihydroxymandelicacid
Normetanephrine (NE);Metanephrine (Epi)
3-methoxy-4-hydroxy-mandelic acid(VMA)
COMT
MAO
Biosynthesis Metabolism
Phenylethanolamine-N-methyltransferase
EPI(Adrenal medulla)
(Sympathetic nerve)
COMT
8/18/2019 Unit 1-Review of ANS
17/27
8/18/2019 Unit 1-Review of ANS
18/27
The Alpha Receptors
http://cdn.pharmacologycorner.com/wp-content/uploads/2010/07/alpha-2-receptors-synapse.gifhttp://cdn.pharmacologycorner.com/wp-content/uploads/2010/07/alpha-1-receptors-synapse.gif
8/18/2019 Unit 1-Review of ANS
19/27
Effects of alpha 1 receptor activation
on different tissues and systems
8/18/2019 Unit 1-Review of ANS
20/27
Postsynaptic Alpha1 Receptors on
Vascular Smooth Muscle
8/18/2019 Unit 1-Review of ANS
21/27
Presynaptic Alpha2 Receptors
• Alpha2 receptors also exist presynaptically
associated with nerve terminals• Activation of these receptors inhibits the release of
NE▫ NE acts at presynaptic alpha2 receptors to inhibit its own
release.
8/18/2019 Unit 1-Review of ANS
22/27
Alpha-2 receptor activation
8/18/2019 Unit 1-Review of ANS
23/27
Drugs affecting alpha receptors
http://cdn.pharmacologycorner.com/wp-content/uploads/2010/07/alpha_blockers_agonists.gif
8/18/2019 Unit 1-Review of ANS
24/27
The Beta receptors
8/18/2019 Unit 1-Review of ANS
25/27
Effect of Beta1 Receptor Activation
on the Heart
8/18/2019 Unit 1-Review of ANS
26/27
Effect of Beta2 Receptor Activation
on Smooth Muscle
• Leads to vascular andnonvascular smoothmuscle relaxation
• Drugs that activate the beta2 receptor can be; ▫ used to treat as asthma
(by relaxing airway smoothmuscle) and
▫ premature labor (byrelaxing uterine smoothmuscle).
8/18/2019 Unit 1-Review of ANS
27/27
Main effects of receptor activation
Adrenoceptor Main effects
1-receptor Vasoconstriction, relaxation of GI smooth
muscle, salivary secretion, and hepatic
glycogenolysis
2 –
receptor Inhibition of transmitter release (Ach andNA), platelet aggregation, contraction of
vascular smooth muscle, inhibition of insulin
release
1-receptor Increased cardiac rate and force
2 -receptor Bronchodilatation, vasodilatation, relaxation
of the visceral smooth muscle, hepatic
glycogenolysis and muscle tremor
3-receptor Lipolysis